Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - OTHER CURRENT LIABILITIES
Other Current Liabilities HALO - Halozyme Therapeutics, Inc.
99.7 M
LAST VALUE
101.99%
2 YEAR CAGR
15.02%
5 YEAR CAGR
7.25%
10 YEAR CAGR